Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Muhammad Usman, MD, Warda Faridi, MD, Muhammad Asad Fraz, MD, Muhammad Junaid Tariq, MD, Saad Ullah Malik, MD, Fnu Sagar, MD, Awais Ijaz, MD, Abid Hussain, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Amna Khalid, MD, Midhat Lakhani, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3239.

https://doi.org/10.1182/blood-2018-99-111930

Published: 2018

Journal Articles

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Amna Khalid, MD, Saher Nasir Amin, MD, Sharoon Samuel, MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Asad Fraz, MD, Muhammad Usman, MD, Awais Ijaz, MD, Arafat Ali Farooqui, MBBS, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5231.

https://doi.org/10.1182/blood-2018-99-116819

Published: 2018

Journal Articles

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Ali McBride, PharmD,MS, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Ali Younas Khan, MD, Sharoon Samuel, MD, Insija Ilyas Selene, MBBS, James Camamo, Cara Chang, PharmD, Jemin Aby Jose, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5667.

https://doi.org/10.1182/blood-2018-99-119736

Published: 2018

Journal Articles

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

Sharoon Samuel, MBBS, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Amna Khalid, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Faiza Jamil, MD, Muhammad Yasir, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Madeeha Shafqat, Ceren Durer, MD, Zunairah Shah, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5629.

https://doi.org/10.1182/blood-2018-99-114019

Published: 2018

Journal Articles

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2018-99-115922

Published: 2018

Journal Articles

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Seren Durer, MD, Fnu Sagar, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Zunairah Shah, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5722.

https://doi.org/10.1182/blood-2018-99-110006

Published: 2018

Journal Articles

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Muhammad Yasir, MD, Muhammad Junaid Tariq, MD, Arshia Akbar, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Muhammad Umair Jahngir, Ali Younas Khan, MD, Awais Ijaz, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5559.

https://doi.org/10.1182/blood-2018-99-117084

Published: 2018

Journal Articles

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Awais Ijaz, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Jahanzeb Khalil, MD, Arveen Asghar, Seren Durer, MD, Ceren Durer, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5649.

https://doi.org/10.1182/blood-2018-99-109944

Published: 2018

Journal Articles

Role of Ibrutinib Based Regimen in Chronic Lymphocytic Leukemia

Muhammad Sardar, MD, Saad Ullah Malik, MD, Ali Younas Khan, MD, Chaudhry Saad Sohail, MD, Malik Qistas Ahmad, MD MBBS, Saher Nasir Amin, MD, Rajshekar Chakraborty, MD, Ali McBride, Muhammad Azharuddin, MD, David Sharon, Patrick Lee, MD, Warda Faridi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5563.

https://doi.org/10.1182/blood-2018-99-110257

Published: 2018

Journal Articles

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Ceren Durer, MD, Seren Durer, MD, Madeeha Shafqat, Zunairah Shah, MBBS, Maryam Sadiq, MBBS, Muhammad Asad Fraz, MD, Malik Qistas Ahmad, MD MBBS, Hafiz Muhammad Fazeel, MD, Sharoon Samuel, MBBS, Mustafa Nadeem Malik, MD, Midhat Lakhani, MD, Chaudhry Saad Sohail, MD, Anum Qureshi, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5742.

https://doi.org/10.1182/blood-2018-99-109998

Published: 2018

Journal Articles

Antibodies in Development for Multiple Myeloma: A Systematic Review

Muhammad Asad Fraz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Yasir, MD, Seren Durer, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Sharoon Samuel, MBBS, Saher Nasir Amin, MD, Ahmad Safdar, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5656.

https://doi.org/10.1182/blood-2018-99-114224

Published: 2018

Journal Articles

Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review

Faiza Jamil, MD, Madeeha Shafqat, Ali Younas Khan, MD, Seren Durer, MD, Ceren Durer, MD, Zunairah Shah, MBBS, Anum Qureshi, Muhammad Abu Zar, MD, Ahmad Kamal, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Insija Ilyas Selene, MBBS, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1948.

https://doi.org/10.1182/blood-2018-99-109986

Published: 2018

NARROW

Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Role of Ibrutinib Based Regimen in Chronic Lymphocytic Leukemia

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Antibodies in Development for Multiple Myeloma: A Systematic Review

Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only